Alyeska Investment Group, L.P. Acumen Pharmaceuticals, Inc. Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 939,603 shares of ABOS stock, worth $2.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
939,603
Previous 939,603
-0.0%
Holding current value
$2.17 Million
Previous $2.27 Million
2.51%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ABOS
# of Institutions
78Shares Held
41.8MCall Options Held
57.7KPut Options Held
749K-
Ra Capital Management, L.P. Boston, MA14.9MShares$34.5 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$8.2 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$7.89 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.31 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$4.99 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $93.6M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...